November 26, 2014 / 7:25 PM / 4 years ago

Medtronic gets US antitrust approval to buy Covidien with divestiture

WASHINGTON, Nov 26 (Reuters) - Medtronic Inc has won U.S. antitrust approval to buy Covidien PLC on condition that it sell its drug-coated balloon catheter business, the Federal Trade Commission said on Wednesday.

Shareholders of the two companies will consider the deal on Jan. 6.

Medtronic announced the deal in June, estimating its value at $42.9 billion.

Reporting by Diane Bartz; Editing by Chizu Nomiyama

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below